References
- Katzman, R. & Saitoh, T. Advances in Alzheimer's disease. FASEB J 5:278-286 (1991) https://doi.org/10.1096/fasebj.5.3.2001787
- Selkoe, D. J. Alzheimer's disease: genes, protein and therapy. Physiol Rev 81:741-766 (2002)
- Mori, H. et al. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. J Biol Chem 267:17082-17086 (1992)
- Stanyer, L., Betteridge, D. J. & Smith, C. C. Exaggerated polymerization of beta-amyloid 40 stimulated by plasma lipoproteins results in fibrillar Abeta preparations that are ineffective in promoting ADP-induced platelet aggregation. Biochim Biophys Acta 1674:305-311 (2004) https://doi.org/10.1016/j.bbagen.2004.07.005
- Ma, J. et al. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372:92-94 (1994) https://doi.org/10.1038/372092a0
- Loo, D. T. et al. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90:7951-7955 (1993) https://doi.org/10.1073/pnas.90.17.7951
- Klein, W. L., Stine, W. B. Jr. & Teplow, D. B. Small assemblies of unmodified amyloid-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol Aging 25:569-580 (2004) https://doi.org/10.1016/j.neurobiolaging.2004.02.010
- Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486-489 (2003) https://doi.org/10.1126/science.1079469
- Seidler, N. W., Craig, H. D. & Squire, T. J. Endogenous plastic composite material in the Alzheimer's brain. Med Hypotheses 67:467-470 (2006) https://doi.org/10.1016/j.mehy.2006.02.038
- Chen, K., Maley, J. & Yu, P. H. Potential implications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis. Journal of Neurochemistry 99:1413-1424 (2006) https://doi.org/10.1111/j.1471-4159.2006.04181.x
-
Dyrks, T. et al. Amyloidogenicity of
$\beta$ A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem 267:18210-18217 (1992) - Mantyh, P. W. et al. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J Neurochem 61:1171-1174(1993) https://doi.org/10.1111/j.1471-4159.1993.tb03639.x
- Bush, A. L. et al. Modulation of A/3 adhesiveness and secretase site cleavage by zinc. J Biol Chem 269:12152-12158 (1994)
- Chen, K., Kazachkov, M. & Yu, P. H. Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer's disease. J Neural Transm 114:835-839 (2007) https://doi.org/10.1007/s00702-007-0697-5
- Butterfield, D. A., Perluigi, M. & Sultana, R. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol 545:39-50 (2006) https://doi.org/10.1016/j.ejphar.2006.06.026
- Lovell, M. A. et al. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158:47-52 (1998) https://doi.org/10.1016/S0022-510X(98)00092-6
- Liu, G. et al. Metal exposure and Alzheimer's pathogenesis. J Struct Biol 155:45-51 (2006) https://doi.org/10.1016/j.jsb.2005.12.011
- Dib, M. et al. Can MDA be used as a biological marker of progression in neurodegenerative disease? J Neurol 249:367-374 (2002) https://doi.org/10.1007/s004150200025
- Hensley, K. et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 65:2146-2156 (1995) https://doi.org/10.1046/j.1471-4159.1995.65052146.x
- Castegna, A. et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 33:562-571 (2002) https://doi.org/10.1016/S0891-5849(02)00914-0
- Castegna, A. et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alphaenolase and heat shock cognate 71. J Neurochem 82:1524-1532 (2002) https://doi.org/10.1046/j.1471-4159.2002.01103.x
- Dei, R. et al. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease. Acta Neuropathol (Berl) 104:113-122 (2002) https://doi.org/10.1007/s00401-002-0523-y
- Sayre, L. M. et al. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68:2092-2097 (1997) https://doi.org/10.1046/j.1471-4159.1997.68052092.x
- Wentworth, P. Jr. et al. Evidence for ozone formation in human atherosclerotic arteries. Science 302:1053-1056 (2003) https://doi.org/10.1126/science.1089525
- Zhang, Q. et al. Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc Natl Acad Sci USA 101:4752-4757 (2004) https://doi.org/10.1073/pnas.0400924101
- Sayer, L. M. et al. Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita 41:143-164 (2005)
-
Chua, C. M. et al. The iron (III) chloride-mediated 1,4-addition of mercaptans to
$\alpha,\beta$ -unsaturated ketones and esters under solvent free conditions. Tetrahedron Letters 47:7375-7380 (2006) https://doi.org/10.1016/j.tetlet.2006.07.151 - Esterbauer, H., Schaur, R. J. & Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol Med 11:81-128 (1991) https://doi.org/10.1016/0891-5849(91)90192-6
- Gubisne-Haberle, D. et al. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine. J Pharmacol Exp Therap 310:1125-1132 (2004) https://doi.org/10.1124/jpet.104.068601
- Kobayashi, S., Kakumoto, K. & Sugiura, M. Transition metal salts-catalyzed aza-Michael reactions of enones with carbamates. Org Lett 4:1319-1322 (2002) https://doi.org/10.1021/ol0256163
- Yamada, S. et al. Immunochemical detection of a lipofuscin-like fluorophore derived from malondialdehyde and lysine. J Lipid Res 42:1187-1196 (2001)
- Sayre, L. M., Moreira, P. I., Smith, M. A. & Perry, G. Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita 41:143-164 (2005)